logo
Select company
Select metric
-3454.54%EBITDA Margin
VS
Market
3
Sector
11
Industry
9
History
24
$ 0.38Close
$ 0.23 - $ 1.32 52-Week Range
Ticker Information

Ticker

CODX

Company Name

CO-DIAGNOSTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

CO-DIAGNOSTICS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CODX - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -34.67M-3454.54%$ 1M
3/31/2025$ -34.48M-985.85%$ 3.5M
12/31/2024$ -36.19M-924.38%$ 3.92M
9/30/2024$ -36.03M-492.12%$ 7.32M
6/30/2024$ -34.5M-377.54%$ 9.14M
3/31/2024$ -38.09M-570.39%$ 6.68M
12/31/2023$ -36.83M-540.69%$ 6.81M
9/30/2023$ -51.05M-1095.8%$ 4.66M
6/30/2023$ -46.42M-636.22%$ 7.3M
3/31/2023$ -38.58M-318.31%$ 12.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CO-DIAGNOSTICS INC's latest trailing twelve months (TTM) EBITDA % stands at 52.87%.
  • Over the past 5 years, CO-DIAGNOSTICS INC's average EBITDA % has been -450.22%.
  • The median EBITDA % for CO-DIAGNOSTICS INC during this period was -184.78%
  • CO-DIAGNOSTICS INC reached its highest EBITDA % over the past 5 years at 57.73%.
  • The lowest EBITDA % recorded by CO-DIAGNOSTICS INC in the same timeframe -3454.54%

CO-DIAGNOSTICS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
PAVM : PAVMED INC 7183.63%POAI : PREDICTIVE ONCOLOGY INC -847.68%APRE : APREA THERAPEUTICS INC -1763.89%LYRA : LYRA THERAPEUTICS INC -4983.38%VTAK : CATHETER PRECISION INC -2519.17%SINT : SINTX TECHNOLOGIES INC -623%HSDT : HELIUS MEDICAL TECHNOLOGIES INC -6972.88%MOVE : MOVANO INC -4239.36%HSCS : HEARTSCIENCES INC -127689.7%BRTX : BIORESTORATIVE THERAPIES INC -1725.43%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for CO-DIAGNOSTICS INC is calculated as follows: EBITDA [ $ 25.12M ] / Revenues [ $ 47.52M ]
(=) EBITDA % [ 52.87% ]

CODX - EBITDA Margin, Last 5 years

-3454.54%

Minimum

Jun 30, 2025

57.73%

Maximum

Mar 31, 2021

-450.22%

Average

-184.78%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%